Related references
Note: Only part of the references are listed.Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy
Sugeevan Savarimuthu et al.
JOURNAL OF CARDIAC SURGERY (2020)
Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
Alexander Afanasyev et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2020)
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto et al.
LANCET (2020)
Alcohol Septal Ablation versus Septal Myectomy Treatment of Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
Ibadete Bytyci et al.
JOURNAL OF CLINICAL MEDICINE (2020)
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Steve R. Ommen et al.
CIRCULATION (2020)
Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis
Josef Veselka et al.
EUROPEAN HEART JOURNAL (2019)
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal
Francesco Pelliccia et al.
EUROINTERVENTION (2019)
Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Denisa Jahnlova et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy
Barry J. Maron et al.
JACC-HEART FAILURE (2018)
The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system
Patrick Fitzgerald et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2018)
Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers
Robert L. Anderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy
Angelika Batzner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy
Keitaro Akita et al.
OPEN HEART (2018)
Results of Ten-Year Follow-Up of Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy
Maksim Kashtanov et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2018)
Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Balance
Paul Sorajja
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
Shi Sum Poon et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2017)
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry
Josef Veselka et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China
Shuo-yan An et al.
SCIENTIFIC REPORTS (2017)
Hypertrophic Obstructive Cardiomyopathy Surgical Myectomy and Septal Ablation
Rick A. Nishimura et al.
CIRCULATION RESEARCH (2017)
Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience
Kunal D. Kotkar et al.
ANNALS OF CARDIOTHORACIC SURGERY (2017)
Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry
Josef Veselka et al.
EUROPEAN HEART JOURNAL (2016)
Low procedure-related mortality achieved with alcohol septal ablation in European patients
Josef Veselka et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Short and long-term outcomes of alcohol septal ablation with the trans-radial versus the trans-femoral approach A single center-experience
Fadi J. Sawaya et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Contemporary techniques for catheter-based intervention for hypertrophic obstructive cardiomyopathy
Thomas Cuisset et al.
EUROINTERVENTION (2016)
Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy US Nationwide Inpatient Database, 2003-2011
Luke K. Kim et al.
JAMA CARDIOLOGY (2016)
Low Operative Mortality Achieved With Surgical Septal Myectomy
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Transaortic Chordal Cutting Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy
Paolo Ferrazzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998-2010])
Sidakpal S. Panaich et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Alcohol septal ablation in hypertrophic cardiomyopathy. 3D contrast echocardiography allows localization and quantification of the extension of intraprocedural vascular recruitment
José Luis Moya Mur et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Effectiveness and Safety Beyond 10 Years of Percutaneous Transluminal Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Jose M. de la Torre Hernandez et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2014)
A Decade of Percutaneous Septal Ablation in Hypertrophic Cardiomyopathy
Angelos G. Rigopoulos et al.
CIRCULATION JOURNAL (2011)
Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography
Christian Sohns et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Ventricular Arrhythmia Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Peter A. Noseworthy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy
Paul Sorajja et al.
CIRCULATION (2008)
Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience
Horst Kuhn et al.
CLINICAL RESEARCH IN CARDIOLOGY (2008)
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Perry Elliott et al.
EUROPEAN HEART JOURNAL (2008)
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Hicham El Masry et al.
CURRENT CARDIOLOGY REVIEWS (2008)
Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy
Yasuhiko Hori et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy
Uma S. Valeti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Does sports activity enhance the risk of sudden cardiac death?
Domenico Corrado et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2006)
Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique
DR Holmes et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2005)
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
SR Ommen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
MV Sherrid et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy - The Baylor experience (1996-2002)
VL Fernandes et al.
CLINICAL CARDIOLOGY (2005)
Alcohol septal ablation versus surgical septal myectomy - Comparison of effects on atrioventricular conduction tissue
DR Talreja et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy
D Monakier et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy:: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome
J Veselka et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2004)
Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy
SM Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy
P Richard et al.
CIRCULATION (2003)
Obstructive hypertrophic cardiomyopathy: Echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
MV Sherrid et al.
ANNALS OF THORACIC SURGERY (2003)
Unexpected transesophageal echocardiographic finding after septal myectomy
M Swaminathan et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2002)
Share Paper
